Evidence map›Paper›PMID 35435729›Full record

ReviewClinical microbiology reviews2022

Class C β-Lactamases: Molecular Characteristics.

Alain Philippon, Guillaume Arlet, Roger Labia, Bogdan I Iorga

Open access · greenAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. International journal of molecular sciences · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Antimicrobial agents and chemotherapy · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Contrasting pH optima of β-lactamases CTX-M and CMY influenceApplied and environmental microbiology · 2026
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Alain PhilipponFaculté de Médecine, Bactériologie, Université de Paris, Paris, France.
Guillaume ArletSorbonne Université, U1135, CIMI-Paris, Paris, France.
Roger LabiaLaboratoire Universitaire de Biodiversité et d'Ecologie Microbienne, Quimper, France.
Bogdan I IorgaUniversité Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, France.ORCID 0000-0003-0392-1350
Centre National de la Recherche Scientifique · FRLaboratoire de Biodiversité et Biotechnologies Microbiennes · FRSorbonne Université · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Class C β-lactamases or cephalosporinases can be classified into two functional groups (1, 1e) with considerable molecular variability (≤20% sequence identity). These enzymes are mostly encoded by chromosomal and inducible genes and are widespread among bacteria, including Proteobacteria in particular. Molecular identification is based principally on three catalytic motifs (

Indexed as

beta-Lactamasesbeta-LactamsAnti-Bacterial AgentsBacterial ProteinsCarbapenemsMicrobial Sensitivity TestsPorinsSerineAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-LactamsCarbapenemsPorinsSerineAmpC β-lactamasescephalosporinasesESACextended-spectrumphylogenyprimary structure

Identifiers

PMID35435729
PMCPMC9491196
OpenAlexW4224130224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.